Skip to main content
logo
MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
6.93
+0.71 (11.41%)
At close: Nov 6, 2026, 4:00 PM EST
7.10
+0.17 (2.45%)
After-hours: Nov 6, 2026, 7:52 PM EST

MapLight Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
385767---
Market Cap Growth
-44.84%----
Enterprise Value
821,053---
Last Close Price
6.9317.57---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.901.67---
P/TBV Ratio
1.111.67---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.060.080.30
Net Debt / Equity Ratio
-0.87-0.65-0.89-1.04-1.02
Net Debt / EBITDA Ratio
1.251.781.241.300.70
Net Debt / FCF Ratio
1.732.161.281.410.78
Quick Ratio
15.7918.806.835.432.20
Current Ratio
16.5220.017.205.692.54
Return on Equity (ROE)
-111.55%-56.19%-83.21%-120.91%-
Return on Assets (ROA)
-67.11%-34.29%-45.41%-54.74%-
Return on Capital Employed (ROCE)
-69.60%-36.50%-68.60%-74.70%-116.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-107.06%-21.02%---
FCF Yield
-45.47%-18.08%---
Buyback Yield / Dilution
-3972.13%-1079.16%-11.60%-18.43%-
SEC Filings: 10-K · 10-Q